Jeffrey S. Price
Directeur Général chez Octamer, Inc.
Profil
Jeffrey S.
Price is currently the Chief Executive Officer, CFO & Director at Octamer, Inc. and the Chairman at Planet Biotechnology, Inc. He previously served as the Director-Supervisory Board at PanGenetics BV and as the Senior Vice President-Research & Development at Cetus Corp.
Postes actifs de Jeffrey S. Price
| Sociétés | Poste | Début |
|---|---|---|
Octamer, Inc.
 Octamer, Inc. Pharmaceuticals: MajorHealth Technology Octamer, Inc. develops pharmaceutical products for acquired immunodeficiency syndrome virus and cancer cells. The company was founded on June 13, 1990 and is headquartered in Walnut Creek, CA. | Directeur Général | - |
Planet Biotechnology, Inc.
 Planet Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Planet Biotechnology, Inc. identifies and develops promising antibodies and receptor-antibody fusion molecules for the treatment and prevention of infectious diseases including emerging diseases and bio-threat agents. The company was is headquartered in Hayward, CA. | Président | 01/01/1998 |
Anciens postes connus de Jeffrey S. Price
| Sociétés | Poste | Fin |
|---|---|---|
| Cetus Corp. | Directeur Technique/Scientifique/R&D | - |
PanGenetics BV
 PanGenetics BV Miscellaneous Commercial ServicesCommercial Services PanGenetics BV researches and develops antibody-based therapeutic products. It specializes in taking antibodies at the late research stage through to clinical proof of concept. The firm’s advanced programs are PG102, a CD40 antagonist, and PG110, an anti-Nerve Growth Factor antibody for use in chronic pain. The company was founded by Mark de Boer and James W. Larrick in 1995 and is headquartered in Utrecht, the Netherlands. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
PanGenetics BV
PanGenetics BV Miscellaneous Commercial ServicesCommercial Services PanGenetics BV researches and develops antibody-based therapeutic products. It specializes in taking antibodies at the late research stage through to clinical proof of concept. The firm’s advanced programs are PG102, a CD40 antagonist, and PG110, an anti-Nerve Growth Factor antibody for use in chronic pain. The company was founded by Mark de Boer and James W. Larrick in 1995 and is headquartered in Utrecht, the Netherlands. | Commercial Services |
Octamer, Inc.
Octamer, Inc. Pharmaceuticals: MajorHealth Technology Octamer, Inc. develops pharmaceutical products for acquired immunodeficiency syndrome virus and cancer cells. The company was founded on June 13, 1990 and is headquartered in Walnut Creek, CA. | Health Technology |
| Cetus Corp. | Health Technology |
Planet Biotechnology, Inc.
Planet Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Planet Biotechnology, Inc. identifies and develops promising antibodies and receptor-antibody fusion molecules for the treatment and prevention of infectious diseases including emerging diseases and bio-threat agents. The company was is headquartered in Hayward, CA. | Health Technology |
